{
    "name": "prilocaine",
    "comment": "Rx",
    "other_names": [
        "Citanest"
    ],
    "classes": [
        "Local Anesthetics",
        "Amides",
        "Local Anesthetics",
        "Dental"
    ],
    "source": "https://reference.medscape.com/drug/citanest-plain-dental-prilocaine-343366",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C",
            "Lactation: not known if excreted in breast milk"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: not known if excreted in breast milk"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to prilocaine, amide-type local anesthetics, sulfites, parabens",
                "Idiopathic or congenital methemoglobinemia"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Administration of >600 mg to adults causes non-acute 15% methemoglobinemia via formation of o-toluidine metabolite",
                "Use preservative-free preparations for spinal or epidural anesthesia",
                "DO NOT use solutions with epinephrine in distal areas of body (e.g. digit, nose, ear, etc)",
                "History of malignant hyperthermia",
                "Respiratory arrest reported with local anesthetics",
                "Seizures reported with systemic toxicity",
                "Addition of vasoconstrictor, epinephrine, will promote local hemostasis, decrease systemic absorption, and increase duration of action"
            ],
            "specific": [
                {
                    "type": "  Methemoglobinemia",
                    "description": [
                        "Use of local anesthetics may cause methemoglobinemia, a serious condition that must be treated promptly; patients with glucose-6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, infants under 6 months of age, and concurrent exposure to oxidizing agents or their metabolites are more susceptible to developing clinical manifestations of the condition",
                        "Advise patients or caregivers to seek immediate medical attention if patient experiences the following signs or symptoms: pale, gray, or blue colored skin (cyanosis); headache; rapid heart rate; shortness of breath; lightheadedness; or fatigue; discontinue Bicillin C-R and any other oxidizing agents; depending on severity of signs and symptoms, patients may respond to supportive care, including oxygen therapy and hydration; a more severe clinical presentation may require treatment with methylene blue, exchange transfusion, or hyperbaric oxygen"
                    ]
                }
            ]
        }
    },
    "interactions": [
        {
            "classification_type": "Serious",
            "interaction_with": "bupivacaine implant",
            "description": {
                "common": "prilocaine, bupivacaine implant.\nEither increases effects of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Avoid additional local anesthetic administration within 96 hr following bupivacaine implantation. If use of additional local anesthetics is unavoidable based on clinical need, monitor for neurologic and cardiovascular effects related to local anesthetic systemic toxicity."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "nadolol",
            "description": {
                "common": "nadolol, prilocaine. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Use extreme caution during concomitant use of bupivacaine and antihypertensive agents."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "phenazopyridine",
            "description": {
                "common": "phenazopyridine increases toxicity of prilocaine by Other (see comment). Modify Therapy/Monitor Closely. \nComment: Phenazopyridine may significantly increase risk of methemoglobinemia when coadministered with prilocaine. Monitor patients closely."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "pindolol",
            "description": {
                "common": "pindolol, prilocaine. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Use extreme caution during concomitant use of bupivacaine and antihypertensive agents."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "propranolol",
            "description": {
                "common": "propranolol, prilocaine. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Use extreme caution during concomitant use of bupivacaine and antihypertensive agents."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "timolol",
            "description": {
                "common": "timolol, prilocaine. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Use extreme caution during concomitant use of bupivacaine and antihypertensive agents."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "hyaluronidase",
            "description": {
                "common": "hyaluronidase, prilocaine. Other (see comment). Minor/Significance Unknown. \nComment: Hyaluronidase hastens the onset of local analgesia and reduces swelling, but increases systemic absorption of anesthetic. This decreases the duration of action and increases incidence of systemic reaction."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "CNS depression manifested by drowsiness",
            "percent": null
        },
        {
            "name": "unconsciousness",
            "percent": null
        },
        {
            "name": "respiratory arrest",
            "percent": null
        },
        {
            "name": "nausea",
            "percent": null
        },
        {
            "name": "vomiting",
            "percent": null
        },
        {
            "name": "chills",
            "percent": null
        },
        {
            "name": "miosis",
            "percent": null
        },
        {
            "name": "tinnitus",
            "percent": null
        },
        {
            "name": "myocardial depression",
            "percent": null
        },
        {
            "name": "bradycardia",
            "percent": null
        },
        {
            "name": "cardiac arrhythmias",
            "percent": null
        },
        {
            "name": "hypotension",
            "percent": null
        },
        {
            "name": "cardiovascular collapse",
            "percent": null
        },
        {
            "name": "cardiac arrest",
            "percent": null
        },
        {
            "name": "palpitation",
            "percent": null
        },
        {
            "name": "headache",
            "percent": null
        },
        {
            "name": "tremors",
            "percent": null
        },
        {
            "name": "tachycardia",
            "percent": null
        },
        {
            "name": "anginal pain",
            "percent": null
        },
        {
            "name": "hypertension",
            "percent": null
        },
        {
            "name": "epinephrine",
            "percent": null
        },
        {
            "name": "containing solutions",
            "percent": null
        },
        {
            "name": "Anxiety",
            "percent": null
        },
        {
            "name": "Apprehension",
            "percent": null
        },
        {
            "name": "Restlessness",
            "percent": null
        },
        {
            "name": "Nervousness",
            "percent": null
        },
        {
            "name": "Disorientation",
            "percent": null
        },
        {
            "name": "Confusion",
            "percent": null
        },
        {
            "name": "Dizziness",
            "percent": null
        },
        {
            "name": "Blurred vision",
            "percent": null
        },
        {
            "name": "Tremors",
            "percent": null
        },
        {
            "name": "Twitching",
            "percent": null
        },
        {
            "name": "Shivering",
            "percent": null
        },
        {
            "name": "Seizures",
            "percent": null
        },
        {
            "name": "Edema",
            "percent": null
        },
        {
            "name": "Status asthmaticus",
            "percent": null
        },
        {
            "name": "Anaphylactoid reactions",
            "percent": null
        },
        {
            "name": "sometimes fatal",
            "percent": null
        }
    ]
}